Enzymatica AB Statistics
Want to see SE:ENZY full AI Analyst Report?
Enzymatica AB (ENZY) Stock Statistics & Valuation Metrics
Total Valuation
Enzymatica AB has a market cap or net worth of SEK 604.41M. The enterprise value is SEK 422.19M.
- Market Cap
- SEK 604.41M
- Enterprise Value
- SEK 422.19M
Share Statistics
Enzymatica AB has 242,735,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 242,735,100
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Enzymatica AB’s return on equity (ROE) is -0.42 and return on invested capital (ROIC) is -41.66%.
- Return on Equity (ROE)
- -0.42
- Return on Assets (ROA)
- -0.37
- Return on Invested Capital (ROIC)
- -41.66%
- Return on Capital Employed (ROCE)
- -0.42
- Revenue Per Employee
- 2.99M
- Profits Per Employee
- -2.88M
- Employee Count
- 18
- Asset Turnover
- 0.38
- Inventory Turnover
- 1.10
Valuation Ratios
The current PE Ratio of Enzymatica AB is -15.00. Enzymatica AB’s PEG ratio is -0.56.
- PE Ratio
- -15.00
- PS Ratio
- 11.83
- PB Ratio
- 6.49
- Price to FCF
- -25.64
- Price to Operating Cash Flow
- -25.82
- PEG Ratio
- -0.56
Income Statement
In the last 12 months, Enzymatica AB had revenue of 53.90M and earned -51.89M in profits. Earnings per share was -0.21.
- Revenue
- 53.90M
- Gross Profit
- 33.13M
- Operating Income
- -52.21M
- Pretax Income
- -51.84M
- Net Income
- -51.89M
- EBITDA
- -46.81M
- Earnings Per Share (EPS)
- -0.21
Cash Flow
In the last 12 months, operating cash flow was -23.60M and capital expenditures -164,000, giving a free cash flow of -23.76M billion.
- Operating Cash Flow
- -23.60M
- Free Cash Flow
- -23.76M
- Free Cash Flow per Share
- -0.10
Dividends & Yields
Enzymatica AB pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -3.90%
- Earnings Yield
- -6.80%
Stock Price Statistics
- Beta
- -0.01
- 52-Week Price Change
- 29.82%
- 50-Day Moving Average
- 1.96
- 200-Day Moving Average
- 2.23
- Relative Strength Index (RSI)
- 62.67
- Average Volume (3m)
- 114.43K
Important Dates
Enzymatica AB upcoming earnings date is Feb 18, 2027, Before Open (Not Confirmed).
- Last Earnings Date
- Oct 29, 2026
- Next Earnings Date
- Feb 18, 2027
- Ex-Dividend Date
- ―
Financial Position
Enzymatica AB as a current ratio of 3.65, with Debt / Equity ratio of 0.82%
- Current Ratio
- 3.65
- Quick Ratio
- 2.59
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.69
- Interest Coverage Ratio
- -42.41
Taxes
In the past 12 months, Enzymatica AB has paid -51.00K in taxes.
- Income Tax
- -51.00K
- Effective Tax Rate
- 0.00
Enterprise Valuation
Enzymatica AB EV to EBITDA ratio is -14.77, with an EV/FCF ratio of -25.94.
- EV to Sales
- 11.97
- EV to EBITDA
- -14.77
- EV to Free Cash Flow
- -25.94
- EV to Operating Cash Flow
- -26.12
Balance Sheet
Enzymatica AB has SEK 6.69M in cash and marketable securities with SEK 13.80M in debt, giving a net cash position of -SEK 7.11M billion.
- Cash & Marketable Securities
- SEK 6.69M
- Total Debt
- SEK 13.80M
- Net Cash
- -SEK 7.11M
- Net Cash Per Share
- -SEK 0.03
- Tangible Book Value Per Share
- SEK 0.39
Margins
Gross margin is 58.77%, with operating margin of -79.41%, and net profit margin of -80.52%.
- Gross Margin
- 58.77%
- Operating Margin
- -79.41%
- Pretax Margin
- -79.36%
- Net Profit Margin
- -80.52%
- EBITDA Margin
- -81.07%
- EBIT Margin
- -81.07%
Analyst Forecast
The average price target for Enzymatica AB is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -2.36%
- EPS Growth Forecast
- 23.44%
Scores
- Smart Score
- ―
- AI Score
- 50
